RESPTALK
Management of Severe Asthma in Children
05.05.2022 Webinar - RespTalk - Professor Leonardo Bacharier
Maj 2022
Følgende emner bliver dækket i sessionen:
- Børn med svær astma
- Sygdomsbyrde og behandlingsmuligheder
- Dupilumab som en behandlingsmulighed til børn med svær astma mellem 6 -11 år
Biografi:
Leonard B. Bacharier, MD Professor of Pediatrics, Janie Robinson and John Moore Lee Chair in Pediatrics,Vanderbilt University Medical Center Nashville, Tennessee, United States
Dr Bacharier’s career has focused on clinical research to help understand and improve the care of children with asthma. His clinical/translational research efforts are directed at the pathogenesis of asthma in early life and approaches to asthma management throughout childhood, including multi-center federally funded clinical trials in asthma. Specifically, he is an investigator in several NIH-funded asthma programs, including the Inner City Asthma Consortium, ORBEX and PrecI SE and the site Principal Investigator for the ALA-ACRC. Dr Bacharier is an author of more than 230 peer reviewed articles within the respiratory field and is an associate editor for The Journal of Allergy and Clinical Immunology, a member of the GINA Science Committee, and past Chair of the American Board of Allergy and Immunology.
MAT-BE-2200048
Dette webinar er forbehold sundhedsfaglige personer og bliver afholdt af Sanofi North Europe. Arrangementet er anmeldt til ENLI (Etisk Nævn for Lægemiddelindustrien) inden arrangementets afholdelse, og arrangementet er efter Sanofi’s opfattelse i overensstemmelse med området, selv om arrangementet ikke på forhånd er godkendt af ENLI.
MAT-DK-2200318/MAT-DK-2200234
Andre events
Nedenfor kan du se hvilke andre events, der måtte have din interesse, som udbydes af Sanofi.
RespTalk
Redefining Pediatric Severe Asthma & the Future of Clinical Management
Speaker: Professor Adnan Custovic
Tirsdag den 22. november 2022